Nonalcoholic Steatohepatitis Unknown Status Phase 2 Trials for Losartan (DB00678)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00699036Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Treatment